Dr. Gill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Meyer 6-145
Baltimore, MD 21287
Education & Training
Johns Hopkins UniversityFellowship, Neuroimmunology & Multiple Sclerosis, 2021 - 2024
University of Pennsylvania Health SystemResidency, Neurology, 2018 - 2021- University of Pennsylvania Health SystemInternship, Internal Medicine, 2017 - 2018
Perelman School of Medicine at the University of PennsylvaniaClass of 2017
University of PennsylvaniaPhD, Neuroscience , 2011 - 2015- Case Western Reserve UniversityB.S./B.S., Biochemistry/Biology , Summa Cum Laude, 2005 - 2009
Certifications & Licensure
PA State Medical License 2017 - 2024- PA State Medical License 2022 - 2024
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Neuroscience Research Training Award American Academy of Neurology, 2023
- Best Platform Presentation Tykeson Fellows Conference, National Multple Sclerosis Society, 2022
- Dichter Translational Research Award University of Pennsylvania, Neurology Residency Program, 2021
- Join now to see all
Clinical Trials
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Start of enrollment: 2022 Aug 30
- Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis Start of enrollment: 2020 Sep 11
Publications & Presentations
PubMed
- 15 citationsEmerging imaging and liquid biomarkers in multiple sclerosis.Alexander J Gill, Emily M Schorr, Sachin P Gadani, Peter A Calabresi
European Journal of Immunology. 2023-08-01 - 29 citationsHeme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infectionAlexander J. Gill, Rolando Garza, Surendra S. Ambegaokar, Benjamin B. Gelman, Dennis L. Kolson
Journal of Neuroinflammation. 2018-03-06 - 10 citationsReactive Astrocytes Derived From Human Induced Pluripotent Stem Cells Suppress Oligodendrocyte Precursor Cell Differentiation.Matthew D Smith, Xitiz Chamling, Alexander J Gill, Hector Martinez, Weifeng Li
Frontiers in Molecular Neuroscience. 2022-01-01
Journal Articles
- Retinal optical coherence tomography in MSSchorr EM, Gill AJ, Saidha S, Calabresi PA, Practical Neurology, 9/2022
Books/Book Chapters
Press Mentions
An Interview with Alexander GillSeptember 9th, 2014
Grant Support
- Targeting NLRX1 to Limit Inflammatory Demyelination and NeurodegenerationAmerican Academy of Neurology2024–2026
- Autoantibodies and Neurologic Immune-Related Adverse Events in Immune Checkpoint Inhibitor TherapyPhysicians Scientist Training Program, Johns Hopkins University2022–2024
- Targeting Neurotoxic Inflammatory Glia and NLRX1 in MS/EAENational Multiple Sclerosis Society and the American Brain Foundation2021–2024
- Heme Oxygenase-1 as a novel therapeutic target in HIV-mediated neurodegenerationNational Institute of Mental Health (NIMH)2014–2017
- Training in HIV PathogenesisNational Institute of Allergy and Infectious Diseases (NIAID)2012–2014
Professional Memberships
- Member
- Consortium of Multiple Sclerosis CentersMember
- National Multiple Sclerosis SocietyMember
- American Neurological AssociationMember
External Links
- ResearchGatehttps://www.researchgate.net/profile/Alexander-Gill/research
- Google Scholarhttps://scholar.google.com/citations?user=HNlrOYYAAAAJ&hl=en
- LinkedInhttps://www.linkedin.com/in/alexander-gill-203288277/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
